Premium
CRISPR Therapeutics AG (0VRQ)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Dr. Naimish PatelChief Medical Officer | -3,79k | 210,58k | Derivative Exercise and Sale | 55,62 | 19,36k | - |
| 2026-05-28 | Dr. Naimish PatelChief Medical Officer | 6,21k | 0,00 | Derivative Exercise and Retained Stock | - | 19,36k | 47,28% |
| 2026-03-20 | Mr. James R. KasingerGeneral Counsel & Secretary | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 94,31k | 3,36% |
| 2026-03-20 | Mr. James R. KasingerGeneral Counsel & Secretary | -3,18k | 148,85k | Derivative Exercise and Sale | 46,78 | 94,31k | - |
| 2026-03-20 | Dr. Samarth KulkarniCEO & Chairman | 9,67k | 0,00 | Derivative Exercise and Retained Stock | - | 255,50k | 3,93% |
| 2026-03-20 | Dr. Samarth KulkarniCEO & Chairman | -10,02k | 468,74k | Derivative Exercise and Sale | 46,78 | 255,50k | - |
| 2026-03-20 | Dr. Raju Yashaswi PrasadCFO | 2,54k | 0,00 | Derivative Exercise and Retained Stock | - | 15,57k | 19,52% |
| 2026-03-20 | Dr. Raju Yashaswi PrasadCFO | -3,71k | 173,46k | Derivative Exercise and Sale | 46,78 | 15,57k | - |
| 2026-03-14 | Dr. Naimish PatelChief Medical Officer | -3,15k | 152,02k | Derivative Exercise and Sale | 48,26 | 13,14k | - |
| 2026-03-14 | Dr. Naimish PatelChief Medical Officer | 4,98k | 0,00 | Derivative Exercise and Retained Stock | - | 13,14k | 60,91% |
| 2026-03-14 | Dr. Raju Yashaswi PrasadCFO | 6,26k | 0,00 | Derivative Exercise and Retained Stock | - | 13,02k | 92,45% |
| 2026-03-14 | Dr. Raju Yashaswi PrasadCFO | -10,62k | 476,28k | Derivative Exercise and Sale | 48,26 | 13,02k | - |
| 2026-03-14 | Mr. James R. KasingerGeneral Counsel & Secretary | 3,43k | 0,00 | Derivative Exercise and Retained Stock | - | 91,24k | 3,90% |
| 2026-03-14 | Mr. James R. KasingerGeneral Counsel & Secretary | -3,45k | 166,50k | Derivative Exercise and Sale | 48,26 | 91,24k | - |
| 2026-03-14 | Dr. Samarth KulkarniCEO & Chairman | 10,28k | 0,00 | Derivative Exercise and Retained Stock | - | 245,83k | 4,36% |
| 2026-03-14 | Dr. Samarth KulkarniCEO & Chairman | -10,35k | 499,44k | Derivative Exercise and Sale | 48,26 | 245,83k | - |
| 2026-03-10 | Mr. James R. KasingerGeneral Counsel & Secretary | 2,70k | 0,00 | Derivative Exercise and Retained Stock | - | 87,82k | 3,17% |
| 2026-03-10 | Mr. James R. KasingerGeneral Counsel & Secretary | -2,80k | 147,84k | Derivative Exercise and Sale | 52,80 | 87,82k | - |
| 2026-03-10 | Dr. Samarth KulkarniCEO & Chairman | 9,45k | 0,00 | Derivative Exercise and Retained Stock | - | 235,56k | 4,18% |
| 2026-03-10 | Dr. Samarth KulkarniCEO & Chairman | -9,80k | 517,33k | Derivative Exercise and Sale | 52,80 | 235,56k | - |
| 2026-02-18 | Dr. Samarth KulkarniCEO & Chairman | 6,28k | 0,00 | Derivative Exercise and Retained Stock | - | 226,11k | 2,86% |
| 2026-02-18 | Dr. Samarth KulkarniCEO & Chairman | -6,97k | 366,32k | Derivative Exercise and Sale | 52,58 | 226,11k | - |
| 2026-02-18 | Mr. James R. KasingerGeneral Counsel & Secretary | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 85,12k | 2,05% |
| 2026-02-18 | Mr. James R. KasingerGeneral Counsel & Secretary | -2,11k | 111,05k | Derivative Exercise and Sale | 52,58 | 85,12k | - |
| 2025-04-03 | Dr. Naimish PatelChief Medical Officer | 1,51k | 49,70k | Achat | 32,96 | 1,51k | - |
| 2026-01-22 | Dr. Raju Yashaswi PrasadCFO | -34,97k | 525,98k | Derivative Exercise and Sale | 45,15 - 60,19 | 6,77k | - |
| 2026-01-20 | Dr. Samarth KulkarniCEO & Chairman | -90,00k | 5,17M | Automatic Disposition | 51,61 - 60,23 | 219,82k | -29,05% |
| 2026-01-06 | Dr. Raju Yashaswi PrasadCFO | -29,70k | 451,01k | Derivative Exercise and Sale | 44,31 - 60,21 | 6,77k | - |
| 2025-12-22 | Dr. Raju Yashaswi PrasadCFO | -10,00k | 559,55k | Automatic Disposition | 55,10 - 56,89 | 6,77k | -59,64% |
| 2025-12-18 | Dr. Samarth KulkarniCEO & Chairman | -30,00k | 0,00 | Other Disposition | - | 309,82k | -8,83% |
| 2025-10-16 | Dr. Samarth KulkarniCEO & Chairman | 49,11k | 0,00 | Derivative Exercise and Retained Stock | - | 339,86k | 16,89% |
| 2025-10-16 | Dr. Samarth KulkarniCEO & Chairman | -50,90k | 3,46M | Derivative Exercise and Sale | 67,91 | 339,86k | - |
| 2025-10-13 | Mr. James R. KasingerGeneral Counsel & Secretary | 1,04k | 0,00 | Derivative Exercise and Retained Stock | - | 83,40k | 1,26% |
| 2025-10-13 | Mr. James R. KasingerGeneral Counsel & Secretary | -1,08k | 71,66k | Derivative Exercise and Sale | 66,60 | 83,40k | - |
| 2025-10-13 | Dr. Samarth KulkarniCEO & Chairman | 4,09k | 0,00 | Derivative Exercise and Retained Stock | - | 290,76k | 1,43% |
| 2025-10-13 | Dr. Samarth KulkarniCEO & Chairman | -4,24k | 282,52k | Derivative Exercise and Sale | 66,60 | 290,76k | - |
| 2025-09-17 | Dr. Samarth KulkarniCEO & Chairman | -6,00k | 0,00 | Other Disposition | - | 286,63k | -2,05% |
| 2025-08-16 | Dr. Samarth KulkarniCEO & Chairman | 11,92k | 0,00 | Derivative Exercise and Retained Stock | - | 292,63k | 4,25% |
| 2025-08-16 | Dr. Samarth KulkarniCEO & Chairman | -13,08k | 760,66k | Derivative Exercise and Sale | 58,15 | 292,63k | - |
| 2025-08-06 | Dr. Douglas A. TrecoLead Independent Director | 20,00k | 1,14M | Achat | 57,03 | 22,00k | 1 000,00% |
| 2025-07-16 | SR One Capital Management, LPSociété | 989,81k | 51,50M | Achat | 52,03 | 2,04M | 94,36% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
